No product or technology called "AI GE" could be verified, but the name points to a documented area: devices from GE-named manufacturers that appear on the U.S. Food and Drug Administration's list of AI-enabled medical devices. In the list as of September 4, 2026, 109 of 1,614 entries (about seven percent) came from manufacturers whose names begin with "GE", more than any of the other manufacturer names checked, and all of them were radiology-panel devices.
Key takeaways
- "AI GE" is not a verified product; the letters GE are shared by several companies, so the article uses the FDA's public device list as its evidence.
- The FDA list held 1,614 entries on its page dated September 4, 2026, of which 1,230 (about 76 percent) were reviewed by the radiology panel.
- Counted by manufacturer name, GE-named firms had 109 entries, ahead of Siemens-named firms (96) and Philips-named firms (49), by this article's own tally.
- The FDA calls the list not comprehensive, so counts are a floor, not a market ranking.
What "AI GE" can and cannot mean
The old page title, "Ai ge - the future of AI technology," gave no definition of its subject. No announcement, paper, or product with the name "AI GE" was found in the sources checked, and a future-oriented headline cannot be verified as written. Several separate companies now use the GE name, including GE HealthCare, GE Aerospace, and GE Vernova. Only one of those fields has a public, regulator-maintained record that can be checked line by line: medical devices that use AI in the United States. This article therefore covers that record and makes no claim about the other businesses or about any future product.
What the FDA list is
The FDA publishes a list of AI-enabled medical devices. It names devices that have met the agency's premarket requirements, including a focused review of safety and effectiveness, and links each to its public database entry. The FDA identifies devices as AI-enabled mainly by AI-related terms in their marketing authorization summaries or device classification. It states plainly that the list is not a comprehensive resource, that summaries omit most information in an application, and that devices whose summaries were not yet public will appear in later updates. It also says it will explore ways to tag devices that use foundation models, including large language models, which means such tools are not yet separately identified.
Reading the table on the page, the earliest entry is dated September 29, 1995, and the most recent final decision shown is June 29, 2026. Of the 1,614 rows, 1,553 are 510(k) submissions, 40 are De Novo requests, and 21 are premarket approvals. A 510(k) is a premarket submission showing that a device is substantially equivalent to a legally marketed device, and the supporting performance data can include clinical data and bench testing. Authorization therefore documents regulatory review, not a measured improvement in patient outcomes.
How GE-named manufacturers appear
Counting rows by manufacturer name is imprecise, because the same company is spelled in many ways in the table (for example "GE Medical Systems, LLC," "GE Healthcare Japan Corporation," and "GE Medical Systems Ultrasound and Primary Care Diagnostics"). The counts below match names that begin with or contain the stated word and are this article's own tally, not an FDA statistic.
| Manufacturer name contains | Entries on the list | Share of 1,614 |
|---|---|---|
| GE (name begins with "GE") | 109 | about 6.8 percent |
| Siemens | 96 | about 5.9 percent |
| Philips | 49 | about 3.0 percent |
| Canon | 46 | about 2.9 percent |
| United Imaging | 45 | about 2.8 percent |
| Aidoc | 35 | about 2.2 percent |
All 109 GE-named entries sit under the radiology panel, and 108 are 510(k) clearances with one premarket approval. By year of final decision, the tally is 1 in 2014, 3 in 2018, 5 in 2019, 15 in 2020, 7 in 2021, 20 in 2022, 15 in 2023, 9 in 2024, 24 in 2025, and 10 in 2026 through June 29. A single row can cover several product variants, so entries are not unit counts of products.
Why radiology dominates
Across the whole list, 1,230 of 1,614 entries, about 76 percent, are in radiology, followed by cardiovascular (154) and neurology (73). The page does not say why. Recent GE-named entries carry product names such as LOGIQ, Voluson, SIGNA, and AIR Recon DL, and the table gives no description of each device's AI function, so details require the linked FDA summary for each submission.
Checks before citing any "AI company" count
- Which list or database produced the count, and what date was it current?
- Does the list claim to be comprehensive? The FDA's does not.
- Were manufacturer name variants merged, and by what rule?
- Does an entry count a product, a submission, or a family of variants?
- Does authorization show clinical benefit, or only regulatory review?
This article gives general information about a public regulatory list. It is not medical advice, a product recommendation, or a ranking of companies.
FAQ
Is there a product called AI GE?
None could be verified. The letters GE are used by multiple unrelated businesses, so the term does not identify one technology.
Does being on the FDA list mean a device works better?
No. The list records devices that went through FDA premarket review. A 510(k) shows substantial equivalence to an existing device and is not proof of better patient outcomes.
Is the FDA list a complete census of AI medical devices?
No. The FDA says it is not comprehensive, and it identifies AI mainly from terms in public summaries.
Why are most AI-enabled devices radiology devices?
The list shows radiology as the lead panel for about 76 percent of entries. Reasons are not given on the page, so any explanation beyond the data is an inference.
Related reading
- how AI and robotics affect society
- artificial intelligence compared with superintelligence
- researchers who shaped AI
- AI applied to environmental problems
More in AI Basics.
Last verified: October 2026
Sources
- Artificial Intelligence-Enabled Medical Devices (list, content current as of September 4, 2026), U.S. Food and Drug Administration, 2026
- Premarket Notification 510(k), U.S. Food and Drug Administration, 2026